Biodexa Pharmaceuticals Plc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
BDRX Nasdaq 2836 www.biodexapharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Biodexa Pharmaceuticals Plc

European Equities Traded in the US as American Depositary Receipts Track Higher in Friday Trading - Oct 16th, 2026 9:06 am
European Equities Traded in the US as American Depositary Receipts Edge Lower in Wednesday Trading - Oct 14th, 2026 9:10 am
Biodexa Reaches 100-Patient Enrollment Milestone in Phase 3 Serenta Trial as Key Analysis Timeline Accelerates - Oct 13th, 2026 7:51 am
Biodexa announces another Serenta milestone with 100 patients enrolled in its registrational Phase 3 trial in FAP - Oct 13th, 2026 6:30 am
The Longview: Fireside Chat with Biodexa CEO Stephen Stamp - Sep 23rd, 2026 4:30 am
BDRX: Enrollment in Phase 3 SERENTA Trial Reaches 92 Patients - Sep 22nd, 2026 5:26 am
European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading - Sep 15th, 2026 9:18 am
Biodexa Enters Into Warrant Exercise Transaction for $2.3 Million in Gross Proceeds - Sep 15th, 2026 6:00 am
Interim results for the six months ended June 30, 2026 - Sep 11th, 2026 2:30 pm
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading - Sep 11th, 2026 9:13 am
European Equities Traded in the US as American Depositary Receipts Track Higher in Wednesday Trading - Sep 2nd, 2026 9:13 am
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Tuesday Trading - Aug 25th, 2026 9:15 am
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading - Aug 20th, 2026 9:17 am
Biodexa announces major milestone for its Serenta registrational Phase 3 trial in FAP - Aug 19th, 2026 6:30 am
European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading - Aug 3rd, 2026 9:05 am
Result of General Meeting - Jul 29th, 2026 2:30 pm
Biodexa Initiates Support Activities for FAP Patients and Treatment Centers in France - Jul 29th, 2026 6:30 am